SynopsisThe global market for Phenylephrine Hydrochloride API was valued at US$ 244 million in the year 2024 and is projected to reach a revised size of US$ 324 million by 2031, growing at a CAGR of 4.2% during the forecast period. The global pharmaceutical mark.....
SynopsisThe global market for Pharmaceutical Grade Norepinephrine Bitartrate was valued at US$ 232 million in the year 2024 and is projected to reach a revised size of US$ 331 million by 2031, growing at a CAGR of 5.3% during the forecast period. The global phar.....
SynopsisThe global market for Amikacin Sulfate API was valued at US$ 194 million in the year 2024 and is projected to reach a revised size of US$ 256 million by 2031, growing at a CAGR of 4.1% during the forecast period. The global pharmaceutical market is 1475 .....
SynopsisThe global market for Kanamycin Sulfate API was valued at US$ 204 million in the year 2024 and is projected to reach a revised size of US$ 266 million by 2031, growing at a CAGR of 3.9% during the forecast period. The global pharmaceutical market is 1475.....
SynopsisThe global market for Fluorouracil API was valued at US$ 299 million in the year 2024 and is projected to reach a revised size of US$ 405 million by 2031, growing at a CAGR of 4.5% during the forecast period. The global pharmaceutical market is 1475 bill.....
SynopsisThe global market for Pharmaceutical Grade Torasemide was valued at US$ 457 million in the year 2024 and is projected to reach a revised size of US$ 661 million by 2031, growing at a CAGR of 5.5% during the forecast period. The global pharmaceutical mark.....
SynopsisThe global market for Gatifloxacin API was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 568 million by 2031, growing at a CAGR of 4.2% during the forecast period. The global pharmaceutical market is 1475 bill.....
SynopsisThe global market for Sevelamer Carbonate API was valued at US$ 441 million in the year 2024 and is projected to reach a revised size of US$ 579 million by 2031, growing at a CAGR of 4.0% during the forecast period. The global pharmaceutical market is 14.....
SynopsisThe global market for Pharmaceutical Grade Famotidine was valued at US$ 486 million in the year 2024 and is projected to reach a revised size of US$ 726 million by 2031, growing at a CAGR of 6.0% during the forecast period. The global pharmaceutical mark.....
SynopsisThe global market for Aprepitant API was valued at US$ 423 million in the year 2024 and is projected to reach a revised size of US$ 574 million by 2031, growing at a CAGR of 4.5% during the forecast period. The global pharmaceutical market is 1475 billio.....
